During the past decade, Lekarna Hradebni s.r.o. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lekarna Hradebni s.r.o." are "Rheumatoid Arthritis" (4 trials), "Ankylosing Spondylitis" (1 trials), "Cardiovascular Disease" (1 trials) and "Spondylitis, Ankylosing" (1 trials). Many other conditions were trialed in "Lekarna Hradebni s.r.o." in a lesser frequency.

Most popular intervention types in "Lekarna Hradebni s.r.o." are "Drug" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "PF-06410293" (2 trials), "Placebo" (2 trials), "Adalimumab" (1 trials), "CP-690,550" (1 trials) and "Etanercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lekarna Hradebni s.r.o." are 7 trials for "All" genders.

Currently, there are NaN active trials in "Lekarna Hradebni s.r.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Lekarna Hradebni s.r.o., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lekarna Hradebni s.r.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".